About Drugs Made In America Acquisition Corp. Units
https://dmaacorp.comDrugs Made In America Acquisition Corp. is a blank check company. It is an exempt company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in Fort Lauderdale, FL.
CEO
Lynn Stockwell
Compensation Summary
(Year )
Ratings Snapshot
Rating : C-
Price Target
Institutional Ownership
KRYGER CAPITAL LTD
Shares:300K
Value:$3.15M
WOLVERINE ASSET MANAGEMENT LLC
Shares:130K
Value:$1.36M
RIVERNORTH CAPITAL MANAGEMENT, LLC
Shares:102.37K
Value:$1.07M
Summary
Showing Top 3 of 8
About Drugs Made In America Acquisition Corp. Units
https://dmaacorp.comDrugs Made In America Acquisition Corp. is a blank check company. It is an exempt company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in Fort Lauderdale, FL.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $263.7K ▲ | $2.18M ▼ | 0% | $0.07 ▲ | $0 ▲ |
| Q2-2025 | $0 | $131.92K ▼ | $2.29M ▲ | 0% | $0.07 ▼ | $-131.92K ▲ |
| Q1-2025 | $0 | $330.93K ▲ | $1.25M ▲ | 0% | $130.51 ▲ | $-330.93K ▼ |
| Q4-2024 | $0 | $279.88 ▼ | $-279 ▲ | 0% | $-0.03 ▼ | $0 ▲ |
| Q3-2024 | $0 | $144.93K | $-144.93K | 0% | $-0.01 | $-144.93K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $717 ▼ | $237.63M ▲ | $7.36M ▲ | $-7.33M ▼ |
| Q2-2025 | $822 ▼ | $235.21M ▲ | $7.2M ▼ | $228M ▲ |
| Q1-2025 | $923 ▼ | $232.81M ▲ | $7.25M ▲ | $225.56M ▲ |
| Q4-2024 | $1.35K ▼ | $550.82 ▼ | $795.67 ▼ | $-244 ▲ |
| Q3-2024 | $2.1K | $426.14K | $591K | $-164.86K |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $785.09K ▼ | $137.91K ▲ | $231.15M ▲ | $-231.3M ▼ | $-105 ▲ | $137.9K ▲ |
| Q2-2025 | $3.69M ▲ | $-300.67K ▼ | $-231.15M | $231.47M ▲ | $-1.27K ▼ | $-300.67K ▼ |
| Q1-2025 | $1.25M ▲ | $-251.24K ▼ | $-231.15M ▼ | $231.4M ▲ | $-428 ▲ | $-251.24K ▼ |
| Q4-2024 | $-279 ▲ | $-106 ▲ | $0 | $-638 ▼ | $-744 ▲ | $-123 ▲ |
| Q3-2024 | $-144.93K | $-57.23K | $0 | $41.23K | $-16K | $-57.23K |
CEO
Lynn Stockwell
Compensation Summary
(Year )
Ratings Snapshot
Rating : C-
Price Target
Institutional Ownership
KRYGER CAPITAL LTD
Shares:300K
Value:$3.15M
WOLVERINE ASSET MANAGEMENT LLC
Shares:130K
Value:$1.36M
RIVERNORTH CAPITAL MANAGEMENT, LLC
Shares:102.37K
Value:$1.07M
Summary
Showing Top 3 of 8